July 17, 2017 / 11:11 AM / 5 months ago

BRIEF-Valeant agrees to sell Obagi Medical Products business

July 17 (Reuters) - Valeant:

* Valeant agrees to sell Obagi Medical Products business

* Valeant - deal for ‍$190 million in cash​

* Says ‍Valeant will use proceeds from sale to permanently repay term loan debt under its senior secured credit facility​

* Valeant - ‍estimates that 2017 revenue and adjusted ebitda (non-gaap) for Obagi business would have been approximately $85 million and $30 million respectively​

* Valeant - ‍certain affiliates of co agreed to sell Obagi medical products business to Haitong International Zhonghua Finance Acquisition Fund I, L.p.​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below